Regeneron Says FDA Approves New Dupixent Pre-Filled Pen

Regeneron Pharmaceuticals and Sanofi said the FDA approved a 300 mg single-dose pre-filled pen for Dupixent.

• The 300 mg pre-filled pen is expected to be available in the U.S. in 3Q of 2020
• NOTE: Earlier, Regeneron, Sanofi Say Dupixent Approved in China

To view the source of this information click here

To contact the reporter on this story:
Hari Govind in San Francisco at hgovind@bloomberg.net

To contact the editor responsible for this story:
Chakradhar Adusumilli at cadusumilli@bloomberg.net

© 2020 Bloomberg L.P. All rights reserved. Used with permission.